Dec 6 (Reuters) - Avid Bioservices Inc CDMO.O :
* AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR SECOND
QUARTER
ENDED OCTOBER 31, 2022 AND RECENT DEVELOPMENTS
* Q2 REVENUE ROSE 33 PERCENT TO $34.8 MILLION
* Q2 LOSS PER SHARE $0.02
* SEES REVENUE GUIDANCE FOR FISCAL 2023 INCREASED TO $145 TO
$150
MILLION
* Q2 EARNINGS PER SHARE VIEW $-0.01, REVENUE VIEW $32.0
MILLION --
REFINITIV IBES DATA
* FY2023 REVENUE VIEW $143.8 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbnkSs9
Further company coverage: CDMO.O
((Reuters.Briefs@thomsonreuters.com;;))